Voices and stories from the front pages of science

Our Long War on Cancer

When President Nixon declared war on cancer in 1971, the arsenal included radiation and a handful of chemotherapy drugs. But the preferred weapon was the scalpel, not just to remove tumors but to diagnose disease. Continue reading

Untapped Drug Development Opportunities Abound

Orphan diseases used to be a lonely place in drug development, but with recent analyses showing high profitability potential, support from disease advocacy organizations, and new therapeutic approaches, biopharmaceutical companies are beginning to embrace rare diseases, including Spinal Muscular Atrophy. Continue reading